ACHE and early-onset autosomal dominant Alzheimer disease: To date, four drugs belonging to two families have been approved for the treatment of Alzheimer’s disease: acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine) and antiglutamatergic drugs (memantine).